Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Elevance Health ELV Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25	Closed	-$9.72K	–	200
2025 Q2	$9.72K	Sell	25 -25	-50%	-$10.1K	﹤0.01%	177
2025 Q1	$21.7K	Buy	+50	New	+$20.1K	0.01%	164
2024 Q4	–	Sell	-30	Closed	-$15.6K	–	188
2024 Q3	$15.6K	Sell	30 -2	-6%	-$1.07K	0.01%	161
2024 Q2	$17.3K	Hold	32	–	–	0.01%	151
2024 Q1	$15.9K	Buy	32 +17	+113%	+$8.46K	0.01%	148
2023 Q4	$7.07K	Buy	+15	New	+$6.94K	﹤0.01%	174

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's ELV Position: Q3 2025 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 25 shares — an estimated $9.72K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in ELV in Q4 2023 and held it in 6 quarters. The position peaked at $21.7K in Q1 2025. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 25 Elevance Health shares in Q3 2025, an estimated $9.72K.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Elevance Health in Q4 2023 and held it in 6 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Elevance Health position peaked at $21.7K in Q1 2025.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q3 2025, filed 14 Nov 2025.